March 19, 2015
WEST LAFAYETTE, Ind. — The American Association for Cancer Research is honoring Philip S. Low with the AACR Award for Outstanding Achievement in Chemistry in Cancer Research.
Low, Purdue University’s Ralph C. Corley Distinguished Professor of Chemistry, will receive the award at the association’s annual meeting April 18-22 in Philadelphia. He will present his award lecture “Ligand-targeted Imaging and Therapeutic Agents for Cancer” on April 21.
The award is given for outstanding, novel and significant chemistry research, which has led to important contributions to the fields of cancer research, diagnosis, treatment or prevention, according to the association.
Low, who also is director of Purdue’s Center for Drug Discovery and associated with the Purdue Center for Cancer Research, is being recognized for his “pioneering development of low molecular weight ligands to deliver attached therapeutic and imaging agents selectively into pathologic cells such as cancer cells,” according to a statement from the association.
Low holds more than 45 U.S. patents and eight drugs stemming from his research into targeting technologies are currently undergoing human clinical trials.
He has received the American Chemical Society’s George and Christine Sosnovsky Award for Cancer Research, the Watanabe Life Sciences Champion of the Year Award, the Roland T. Lakey Award and the Mathias P. Mertes Award. He also is a fellow of the National Academy of Inventors.
More information is included in the association’s press release available at http://www.aacr.org/Newsroom/Pages/News-Release-Detail.aspx?ItemID=674
Writer: Elizabeth K. Gardner, 765-494-2081, firstname.lastname@example.org
Source: Philip Low, 765-494-5273, email@example.com